MARC details
000 -LEADER |
fixed length control field |
02108cam a2200289 4500 |
001 - CONTROL NUMBER |
control field |
9289013028 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9289013028 |
035 ## - |
-- |
(Sirsi) 9289013028 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 20 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
920304s1991 1 0 eng |
245 00 - TITLE STATEMENT |
Title |
Clinical pharmacology : |
Remainder of title |
the European challenge. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
Copenhagen : |
Name of publisher, distributor, etc. |
WHO Regional Office for Europe, |
Date of publication, distribution, etc. |
1991. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
84 p. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
WHO regional publications. |
Name of part/section of a work |
European series |
Volume/sequential designation |
no. 39 |
520 3# - SUMMARY, ETC. |
Summary, etc. |
Reports the results of a survey on the academic status of clinical pharmacology in the medical schools and health ministries of 21 European countries. The book opens with three articles assessing the status of clinical pharmacology in Europe. These articles discuss the main functions of clinical pharmacology in the national health system, patient care, teaching and research, describe basic principles for the teaching of clinical pharmacology and the training of specialists, and propose measures that can help bring the expertise of clinical pharmacology into routine medical care. The advantages of establishing clinical pharmacology as a permanent discipline in medical schools are also presented and explained. The main contributions of clinical pharmacology are identified as improving the scientific basis of therapeutic decisions, encouraging the individualization of drug therapy, and improving the research component of drug development. The main part of the book consists of brief reports on the organization and teaching of clinical pharmacology in the medical schools of each of 21 European countries. Points covered include the recognition of clinical pharmacology as a specialty, number of posts and departments, future plans, and national associations. |
546 ## - LANGUAGE NOTE |
Language note |
eng. |
550 ## - ISSUING BODY NOTE |
Issuing body note |
WHODOC |
561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
History |
WHO monograph |
565 8# - CASE FILE CHARACTERISTICS NOTE |
Number of cases/variables |
EUR/ICP/DSE 145 |
596 ## - |
-- |
4 |
650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacology, Clinical |
General subdivision |
education. |
651 #2 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Geographic name |
Europe. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
Topical term or geographic name as entry element |
Education and Training. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health Organization. |
Subordinate unit |
Regional Office for Europe. |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
NLM Classification Scheme |
Koha item type |
Books |